Boston Trust Walden Corp Sells 7,856 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

Boston Trust Walden Corp lessened its holdings in shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 1.5% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 510,819 shares of the company's stock after selling 7,856 shares during the period. Boston Trust Walden Corp owned 3.36% of U.S. Physical Therapy worth $36,963,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. CBIZ Investment Advisory Services LLC grew its stake in shares of U.S. Physical Therapy by 59.8% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company's stock worth $29,000 after buying an additional 122 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. purchased a new stake in shares of U.S. Physical Therapy in the fourth quarter worth $39,000. Venturi Wealth Management LLC increased its holdings in shares of U.S. Physical Therapy by 3,200.0% during the fourth quarter. Venturi Wealth Management LLC now owns 726 shares of the company's stock valued at $64,000 after acquiring an additional 704 shares in the last quarter. Fifth Third Bancorp increased its holdings in shares of U.S. Physical Therapy by 34.6% during the first quarter. Fifth Third Bancorp now owns 1,030 shares of the company's stock valued at $75,000 after acquiring an additional 265 shares in the last quarter. Finally, Lazard Asset Management LLC purchased a new position in shares of U.S. Physical Therapy in the 4th quarter worth about $84,000.

Analyst Ratings Changes

USPH has been the topic of several recent analyst reports. William Blair reissued a "market perform" rating on shares of U.S. Physical Therapy in a research report on Thursday, February 27th. Barrington Research cut their price target on shares of U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating on the stock in a report on Friday, February 28th. JMP Securities reissued a "market outperform" rating and set a $113.00 price target on shares of U.S. Physical Therapy in a research report on Tuesday, April 22nd. JPMorgan Chase & Co. lowered their price objective on U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating on the stock in a research report on Wednesday, March 19th. Finally, Wall Street Zen upgraded U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research note on Thursday, May 8th. Two research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $109.00.

U.S. Physical Therapy Stock Performance

Shares of USPH traded up $0.69 during mid-day trading on Friday, hitting $74.48. 213,122 shares of the company traded hands, compared to its average volume of 117,904. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.17 and a current ratio of 1.17. The stock has a 50-day moving average price of $73.93 and a two-hundred day moving average price of $80.72. U.S. Physical Therapy, Inc. has a 1 year low of $62.77 and a 1 year high of $101.20. The stock has a market cap of $1.13 billion, a price-to-earnings ratio of 34.17, a P/E/G ratio of 3.58 and a beta of 1.45.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last posted its earnings results on Wednesday, May 7th. The company reported $0.48 EPS for the quarter, topping analysts' consensus estimates of $0.46 by $0.02. The business had revenue of $183.79 million during the quarter, compared to the consensus estimate of $176.78 million. U.S. Physical Therapy had a net margin of 4.57% and a return on equity of 7.89%. The firm's revenue was up 18.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.51 EPS. Equities analysts anticipate that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current year.

U.S. Physical Therapy Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, June 13th. Shareholders of record on Friday, May 23rd were given a $0.45 dividend. The ex-dividend date was Friday, May 23rd. This represents a $1.80 annualized dividend and a yield of 2.42%. U.S. Physical Therapy's payout ratio is 82.57%.

Insider Buying and Selling at U.S. Physical Therapy

In other news, Director Nancy Ham sold 400 shares of U.S. Physical Therapy stock in a transaction on Thursday, June 12th. The shares were sold at an average price of $78.01, for a total transaction of $31,204.00. Following the transaction, the director now owns 2,594 shares in the company, valued at $202,357.94. This trade represents a 13.36% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Corporate insiders own 2.00% of the company's stock.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.